BrightPath Biotherapeutics Co Ltd 4594.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
87.00quote price arrow up+1.00 (+1.16%)
Volume
158,600
52 week range
81.00 - 193.00
Loading...
  • Open85.00
  • Day High87.00
  • Day Low85.00
  • Prev Close86.00
  • 52 Week High193.00
  • 52 Week High Date07/01/21
  • 52 Week Low81.00
  • 52 Week Low Date05/17/22

Key Stats

  • Market Cap37.06M
  • Shares Out55.25M
  • 10 Day Average Volume498,740
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-22.32

KEY STATS

  • Open85.00
  • Day High87.00
  • Day Low85.00
  • Prev Close86.00
  • 52 Week High193.00
  • 52 Week High Date07/01/21
  • 52 Week Low81.00
  • 52 Week Low Date05/17/22
  • Market Cap37.06M
  • Shares Out55.25M
  • 10 Day Average Volume498,740
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-22.32

RATIOS/PROFITABILITY

  • EPS (TTM)-29.90
  • P/E (TTM)-2.91
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BrightPath Biotherapeutics Co Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BrightPath Biotherapeutics Co., Ltd. is a Japan-based company mainly engaged in the development of pharmaceutical products. The Company is a biopharmaceutical venture company focused on developing cancer immunotherapeutic. The Companies business model covers drug discovery research and early clinical development of cancer immunotherapy; conducting of early-phase clinical trials; and development, manufacturing, and launching of the drugs as commercial products in Japan and...
Kenichi Nagai
President, Chief Executive Officer, Representative Director
Yutaka Waki
Chief Operating Officer, Director of Research Development, Director
Address
Chiyoda-ku, TKY
102-0083
Japan